It has been reported that SSRP1 is highly expressed in many cancers, including colorectal cancer (Wang et al., 2019; Wu et al., 2019), prostate cancer, lung cancer (Bi et al., 2019), bladder cancer (Song et al., 2021), breast cancer (Koman et al., 2012), malignant melanomas (Yu et al., 2021), hepatocellular carcinomas (Luo et al., 2021), and gliomas (Liao et al., 2017). Here, SSRP1 is linked to prostate carcinoma.